---
title: "The pharmaceutical sector fluctuates and strengthens, with multiple stocks hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250504334.md"
description: "The pharmaceutical sector fluctuated and strengthened, with PHARMABLOCK rising over 15%. Multiple stocks, including Yatai pharm, CISEN, Zhongsheng Pharmaceutical, and Luoxin Pharmaceutical, hit the daily limit, while HITECK and EASTON BIOPHARMACEUTICALS surged"
datetime: "2025-07-29T02:35:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250504334.md)
  - [en](https://longbridge.com/en/news/250504334.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250504334.md)
generator: "portal-rs"
---

# The pharmaceutical sector fluctuates and strengthens, with multiple stocks hitting the daily limit

The pharmaceutical sector fluctuated and strengthened, with PHARMABLOCK rising over 15%. Multiple stocks, including Yatai pharm, CISEN, Zhongsheng Pharmaceutical, and Luoxin Pharmaceutical, hit the daily limit, while HITECK and EASTON BIOPHARMACEUTICALS surged

### Related Stocks

- [300725.CN](https://longbridge.com/en/quote/300725.CN.md)
- [002370.CN](https://longbridge.com/en/quote/002370.CN.md)
- [603367.CN](https://longbridge.com/en/quote/603367.CN.md)
- [002793.CN](https://longbridge.com/en/quote/002793.CN.md)
- [300683.CN](https://longbridge.com/en/quote/300683.CN.md)
- [688513.CN](https://longbridge.com/en/quote/688513.CN.md)

## Related News & Research

- [Solar Innovation Reports Regulatory Notice on Significant Shareholding Change](https://longbridge.com/en/news/296636597.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [Dovre Group H1 2026 operating loss narrows to EUR 1 million; net sales rise 22.2% to EUR 1.1 million](https://longbridge.com/en/news/296462184.md)
- [Rompetrol Rafinare invests RON 27 million in 4.8-MW solar plant, 9-MWh storage at Vega refinery](https://longbridge.com/en/news/296623025.md)
- [04:20 ETSphingoTec to Engage with Clinical and Industry Partners at Major 2026 Conferences](https://longbridge.com/en/news/296322953.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**